Vance Street Capital has broadened its presence in the medical and life science manufacturing sector with the acquisition of Injectech, a Colorado-based specialist in precision fluid management components. The deal, announced in Scottsdale, Arizona, establishes Injectech as the newest addition to the firm’s expanding VSC Medical Molding platform.
The deal marks Vance Street’s third medical and life sciences acquisition in 2025, following its earlier purchases of Zenith Adhesive Component and MRPC. Injectech joins two existing platform companies, Plastic Design Company and Resenex, both of which have been integrated into the VSC Medical Molding business over the past four years.
With Injectech’s capabilities now part of the platform, VSC Medical Molding will expand its offering of single-use fluid management solutions across medical device, life science and bioprocessing markets. The combined platform will be able to serve a larger customer base through a wider component portfolio and enhanced custom manufacturing, molding, and tooling capabilities. The fluid management division will now operate under Injectech and Resenex, enabling the business to address a broader set of applications requiring precision fluid control.
Founded in 1998, Injectech brings more than 2 decades of experience as a supplier to global medical device OEMs and bioprocessing manufacturers. The company specializes in high-precision resin components, including luer locks, tube connectors, valves, spikes, and other custom-engineered parts produced through clean-room molding and assembly.
Plastic Design Company, acquired in 2021, strengthens the platform with expertise in micro and high-precision molding, particularly in advanced materials such as PEEK, COC, and COP. Resenex, acquired in 2024, contributes a portfolio of high-flow valves, connectors, and fluid path components serving segments including infusion, wound care, surgical, and in-vitro diagnostics.
Vance Street Capital emphasized that the platform strategy aims to build a comprehensive precision-molding and fluid-management business serving high-growth markets that increasingly depend on reliable, single-use components.
KEY QUOTES:
“We are delighted to welcome Injectech to the VSC Medical Molding family. By combining VSC Medical Molding’s precision molding and in-house tooling capabilities with Injectech’s extensive component portfolio of custom and standard fluid management solutions, we are expanding our ability to deliver specialized solutions for our customers across critical medical, life science and bioprocessing applications.”
Jeff Kyle, CEO, VSC Medical Molding
“We are excited about the next chapter of growth and our partnership with VSC Medical Molding and Vance Street. This combination will accelerate Injectech’s growth and product innovation, further enhancing our ability to meet the evolving needs of our customers.”
Jeff Wicks, CEO, Injectech
“Injectech strengthens our VSC Medical Molding platform with deep expertise in precision fluid management and a culture of innovation. Together, we will continue building a leading precision molding and fluid management platform serving the medical device, life science and bioprocessing industries.”
Steve Sandbo, Partner, Vance Street Capital
